MML Investors Services’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Buy
55,948
+17,718
+46% +$471K ﹤0.01% 1732
2026
Q1
$1.03M Sell
38,230
-1,019
-3% -$30.5K ﹤0.01% 1768
2025
Q4
$1.21M Buy
39,249
+1,261
+3% +$39.3K ﹤0.01% 1681
2025
Q3
$1.17M Sell
37,988
-588
-2% -$14.3K ﹤0.01% 1636
2025
Q2
$797K Sell
38,576
-8,150
-17% -$167K ﹤0.01% 1790
2025
Q1
$915K Buy
46,726
+2,615
+6% +$54.9K ﹤0.01% 1636
2024
Q4
$921K Sell
44,111
-29,150
-40% -$640K ﹤0.01% 1559
2024
Q3
$1.79M Buy
73,261
+3,785
+5% +$101K 0.01% 1156
2024
Q2
$1.75M Sell
69,476
-11,769
-14% -$334K 0.01% 1102
2024
Q1
$2.43M Buy
81,245
+6,155
+8% +$181K 0.01% 968
2023
Q4
$2.39M Buy
75,090
+24,708
+49% +$776K 0.01% 915
2023
Q3
$1.78M Buy
50,382
+9,530
+23% +$363K 0.01% 942
2023
Q2
$1.55M Buy
40,852
+5,986
+17% +$239K 0.01% 1010
2023
Q1
$1.32M Sell
34,866
-1,676
-5% -$64.4K 0.01% 945
2022
Q4
$1.55M Buy
36,542
+3,019
+9% +$124K 0.01% 932
2022
Q3
$1.08M Buy
33,523
+8,033
+32% +$282K 0.01% 1024
2022
Q2
$828K Buy
25,490
+46
+0.2% +$1.49K 0.01% 1136
2022
Q1
$921K Sell
25,444
-1,096
-4% -$37.6K 0.01% 1132
2021
Q4
$1.05M Buy
26,540
+1,973
+8% +$82.3K 0.01% 1039
2021
Q3
$1.07M Buy
24,567
+2,388
+11% +$107K 0.01% 991
2021
Q2
$906K Buy
22,179
+2,348
+12% +$90.6K 0.01% 1041
2021
Q1
$651K Buy
19,831
+4,043
+26% +$152K 0.01% 1129
2020
Q4
$642K Buy
15,788
+2,981
+23% +$111K 0.01% 1035
2020
Q3
$469K Buy
12,807
+755
+6% +$27.3K 0.01% 1072
2020
Q2
$408K Buy
+12,052
New +$328K 0.01% 1083

Other funds holding GMAB

MML Investors Services's GMAB Position: Q2 2026 in Review

MML Investors Services increased its Genmab (GMAB) stake by 46% in Q2 2026, buying an estimated $471K and bringing the position to 55,948 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1732.

MML Investors Services first reported a position in GMAB in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.43M in Q1 2024. 135 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • MML Investors Services held 55,948 shares of Genmab worth $1.54M as of Q2 2026.
  • MML Investors Services bought 17,718 Genmab shares in Q2 2026, an estimated $471K.
  • Genmab made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #1732 holding.
  • MML Investors Services first reported a position in Genmab in Q2 2020 and has held it in 25 quarters since.
  • MML Investors Services's Genmab position peaked at $2.43M in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.